This brand name is authorized in Austria, Estonia, Finland, Lithuania, Netherlands
The drug TRUXAL contains one active pharmaceutical ingredient (API):
|
1
Chlorprothixene
UNII 268KCR965N - CHLORPROTHIXENE HYDROCHLORIDE
|
|
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N05AF03 | Chlorprothixene | N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AF Thioxanthene derivatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EE | Ravimiamet | Identifier(s): 1006063, 1006096 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 149815, 155390, 155432 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1056641, 1056642 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 66613, 66621 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
